drugset / Trial / NCT03341741
Combined Dry Powder Tobramycin and Nebulized Colistin Inhalation in CF Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
To assess whether the inhalative combination of Tobramycin/Colistin is more effective in reducing Pseudomonas colony forming units (CFUs) and improvement of lung function than Colistin in mono-therapy.
Timeline
- Start
- 2014-03-11
- Primary completion
- 2015-12-19
- Completion
- 2016-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Colistin | Other / unclassified | 1 unknown | Inhaled |
| Subject | Tobramycin | Small molecule | 112 mg | Inhaled |